Stereoselective hydrogenation of olefins using rhodium-substituted carbonic anhydrase - A new reductase

Chemistry - A European Journal

Volumn 15, Issue 6, 2009, Pages 1370-1376

  Jing, Qing ^a   Okrasa, Krzysztof ^a   Kazlauskas, Romas J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Carbonic anhydrase; Enzyme catalysis; Hydrogenation; Metalloenzymes; Protein modifications

Indexed keywords

BINDING SITES; CATALYSIS; CATALYST SELECTIVITY; ENZYME ACTIVITY; HYDROGEN; HYDROGENATION; LIGANDS; OLEFINS; REACTION KINETICS; RHODIUM; STEREOSELECTIVITY; SUBSTRATES; TRANSITION METALS;

ACTIVE SITES; CARBONIC ANHYDRASE; COFACTOR; ENZYME CATALYSIS; ENZYME-CATALYZED REACTIONS; HISTIDINE RESIDUES; HYDROGENATION OF OLEFINS; METALLOENZYMES; NON-SPECIFIC BINDINGS; ORGANIC MOLECULES; ORGANIC SUBSTRATES; PROTEIN MODIFICATIONS; PROTEIN SURFACES; RHODIUMS (I); SITE-DIRECTED MUTAGENESIS; STEREOSELECTIVE HYDROGENATIONS; SYNTHETIC REACTIONS; TRANS STILBENES;

ENZYMES;

ALKENE; CARBONATE DEHYDRATASE; OXIDOREDUCTASE; RHODIUM; ZINC;

ARTICLE; BIOCATALYSIS; CHEMICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; DIALYSIS; HYDROGENATION; ISOMERISM; METABOLISM; SURFACE PROPERTY;

ALKENES; BIOCATALYSIS; CARBONIC ANHYDRASES; COMPUTER SIMULATION; DIALYSIS; HYDROGENATION; ISOMERISM; MODELS, CHEMICAL; OXIDOREDUCTASES; RHODIUM; SURFACE PROPERTIES; ZINC;

EID: 60749117181     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.200801673     Document Type: Article

References (58)

1. Reviews: a) P. M. Vignais. B. Billoud, J. Meyer. FEMS Microbiol. Rev. 2001, 25, 455-501;
2. b) M. Frey, ChemBioChem 2002, 3, 153-160;
3. c) The Hmd class of hydrogenases use a cofactor. but hydrogen atoms still end up as protons in water: S. Shima, R. K. Thauer, Chem. Rec. 2007, 7, 37-46.
4. Reviews: a) D. Qi, C.-M. Tann, D. Haring, M. D. Distefano, Chem. Rev. 2001, 101, 3081-3112;
5. b) C. M. Thomas, T.R. Ward, Chem. Soc. Rev. 2005, 34, 337-346;
6. c) C. Lelondor, T. R. Ward, ChemBio-chem 2006, 7, 1845-1852.
7. a) M. E. Wilson, G. M. Whitesides, J. Am Chem. Soc. 1978, 100, 306-307;
8. b) C. C. Lin, C. W. Lin, A. S. C. Chan, Tetrahedron: Asymmetry 1999, 10, 1887-1893;
9. c) J. Collot, J. Gradinaru, N. Humbert, M. Skander, A. Zocchi, T. R. Ward, J. Am. Chem. Soc. 2003, 125, 9030-9031;
10. d) M. Skander. N. Humbert, J. Collot, J. Gradinaru, G. Klein, A. Loosli, J. Sauser, A. Zocchi. F. Gilardoni, T. R. Ward, J. Am. Chem. Soc. 2004, 126, 14411-14418;
11. e) T. R. Ward, Chem. Eur. J. 2005, 11, 3798-3804;
12. f) M. Skander, C. Malan, A. Ivanova, T. R. Ward, Chem. Commun. 2005, 4815-4817;
13. g) C. Lelondor, N. Humbert, T. R. Ward, Proc. Natl. Acad. Sci. USA 2005, 102. 4683-4687;
14. h) L. Panella, J. Broos. J. Jin, M. W. Fraaije, D. B. Janssen, M. Jeronimus-Stratingh, B. L. Feringa, A. J. Minnaard, J. G. de Vries, Chem. Commun. 2005, 5656-5658;
15. i) C. Lelondor; A. Pordea, N. Humbert, A. Ivanova, S. Mazurek, M. Novic, T. R. Ward, J. Am. Chem. Soc. 2006, 128, 8320-8328;
16. j) G. Klein, N. Humbert. J. Gradinaru, A. Ivanova, F. Gilardoni, U. E. Rusbandi, T. R. Ward, Angew. Chem. 2005, 117, 7942- 7945;
17. Angew. Chem. Int. Ed. 2005, 44, 7764-7767.
18. H. Yamaguchi, T. Hirano, H. Kiminami, D. Taura, A. Harada, Org. Biomol. Chem. 2006, 4, 3571-3573.
19. a) B. P. Espósilo, E. de Oliveira, S. B. Zyngier, R. Najjar, J. Braz, Chem. Soc. 2000, 11, 447-452;
20. b) B. P. Espósito, A. Faljoni-Alário, J. F. S. de Menezes, H. F. de Brito, R. Najjar, J. Inorg. Biochem. 1999, 75, 55-61;
21. c) the interest in the binding of these complexes to proteins stems from reports of their anti-cancer activity: J. L. Bear, H. B. Gray, L. Rainen, I. M. Chang, R. A. Howard, G. Serio, A. P. Kimball, Cancer Chemother. Rep. 1975, 159, 611-620.
22. a) L. Trynda, F. Pruchnik, J. Inorg. Biochem. 1995, 58, 69-77;
23. b) L. Trynda-Lemiesz, F. Pruchnik, J. Inorg. Biochem. 1997, 66, 187-192.
24. C. Bertucci, C. Botteghi, D. Giunta, M. Marchetti, S. Paganelli. Adv. Synth. Catal. 2002, 344, 556-562;
25. a preliminary communication from this group (M. Marchetti. G. Mangano, S. Paganelli. C. Botteghi, Tetrahedron Lett. 2000, 41, 3717-3720) mentioned enantioselectivity for one substrate and selective hydroformylation of smaller aldehydes over larger ones, but this full paper did not confirm the preliminary report.
26. T. Ueno, M. Suzuki, T Goto. T. Matsumoto, K. Nagayama. Y. Watanabe, Angew. Chem. 2004, 116, 2581-2584;
27. Angew. Chem. Int. Ed. 2004, 43, 2527-2530.
28. Zinc(II) has a radius of 0.74 Å, while rhodium(III) has a radius of 0.68 Å (CRC Handbook of Chemistry and Physics. 59th ed, 1978-1979, p. F-213). The ionic radius of rhodium(1) will be > 0.68 Â and likely similar to that for zinc(11).
29. Review: D.W. Christianson, J. D. Cox. Annu. Rev. Biochem. 1999, 68. 33-57.
30. a) K. Okrasa, R.J. Kazlauskas, Chem. Eur. J. 2006, 12, 1587-1596;
31. b) A. Fernández-Gacio. A. Codina. J. Fastrez, O. Raint, P. Soumillon, ChemBioChem 2006, 7, 1013-1016.
32. a) R. G. Wilkins. K. R. Williams, J. Am. Chem. Soc. 1974, 96, 2241-2245;
33. b) Y. Kidani, J. Hirose, H. Koike, J. Biochem. 1976, 79, 43-51;
34. c) Y. Kidani, J. Hirose, J. Biochem. 1977, 81, 1383-1391.
35. S. K. Nair, T. L. Calderone, D. W. Christianson, C. A. Fierke, J. Biol. Chem. 1991, 266, 17320-17325.
36. a) M. Bradford, Anal. Biochem. 1976, 72, 248-254.
37. 4 and bipyridine-[Rh] solutions are pale yellow and have indistinguishable UV/Vis spectra. Similarly, the hCAII 9*His-[Rh] complex shows a similar spectrum with an additional strong absorption at 280 nm due to protein.
38. X-ray structure: A. E. Eriksson, P. M. Kylsten, T A. Jones, A. Liljas, Proteins 1988, 4, 283-293. The Supporting Information includes a graphic showing the location of these histidines.
39. Bovine CA II has no cysteine residues, but the human enzyme has one at position 206, which is buried. Site-directed mutagenesis suggested that it does not bind rhodium.
40. K. L. Gudiksen, I. Gitlin, J. Yang, A. R. Urbach, D. T. Moustakas, G. M. Whitesides. J. Am. Chem. Soc. 2004, 126, 4707-4714.
41. Wild-type hCAII and several variants precipitated after treatment with DEPC or after subsequent exchange of the zinc with rhodium. The triple mutant H4/10R + H17F was an exception since it retained 90% activity in the hydrolysis of 4-nitrophenyl acetate after treatment with DEPC and remained soluble after exchange of the zinc with rhodium.
42. M and ftcat are difficult to measure accurately with the high pressure reaction chambers. For this reason, we focused on selectivity where we measure the relative, not absolute, amounts of products.
43. R. S. Alexander, S. K. Nair, D. W. Christianson, Biochemistry 1991, 30, 11064-11072.
44. X-ray structures of rhodium(1)-olefin complexes show Rh-C distances of approximately 2 Å: J. A. Evans. D. R. Russell, J. Chem. Soc. D 1971, 197-198.
45. R. N. Armstrong. Biochemistry 2000, 39, 13625-13632.
46. K. Yamamura, E. T. Kaiser, J. Chem. Soc. Chem. Commun. 1976, 830-831.
47. M. Bakker, F. van Rantwijk, R. A. Sheldon. Can. J. Chem. 2002, 80, 622-625.
48. a) N. Tanaka, V. Dumay, Q. Liao, A. J. Lange, R. Wever, Eur. J. Biochem. 2002, 269, 2162-2167;
49. b) F. van de Velde, L. Könemann, F. van Rantwijk, R. A. Sheldon, Chem. Commun. 1998, 1891-1892;
50. c) F. van de Velde. L. Künemann, F. van Rantwijk, R. A. Sheldon, Biotechnol. Bioeng. 2000, 67, 87-96.
51. Aqueous-Phase Organometallic Catalysis, 2nd ed. (Eds: B. Cornils, W. A. Herrmann), Wiley-VCH. Weinheim, 2004.
52. A. Liljas, M. Laurberg, EMBO Rep. 2000, 1, 16-17.
53. W. Asmara. U. Murdiyatmo. A.J. Baines, A. T Bull, D.J. Hardman, Biochem. J. 1993, 292, 69-74.
54. Pressure is not the cause of the unstability since the protein precipitates over several hours even under 1 atm of hydrogen.
55. a) T. A. Halgren, J. Comput. Chem. 1996, 17. 490-519;
56. T. A. Halgren, Comput. Chem. 19. 17, 520-552;
57. T. A. Halgren, J. Comput. Chem. 1996, 17, 553-586;
58. b) T. A. Halgren, R. B. Nachbar, J. Comput. Chem. 1996, 17, 587-615.